Traditional Chinese medicinal composition for treating cirrhosis and portal hypertension with syndromes of liver stagnation and spleen deficiency as well as blood stasis

Abstract

The invention belongs to the technical field of a medicine, and in particular relates to a traditional Chinese medicinal composition for treating cirrhosis and portal hypertension with syndromes of liver stagnation and spleen deficiency as well as blood stasis. The traditional Chinese medicine consists of the following traditional Chinese medicinal materials in parts by weight: 8-16 parts of ginkgo root, 5-13 parts of root of Aralia dumetorum Hand.-Mazz., 5-13 parts of radix paeoniae alba, 4-8 parts of shrubberry rhodiola root, 8-16 parts of rust-coloured crotalaria herb with root, 4-8 parts of altai mountain centaurium herb with flower, 4-8 parts of blin conyza herb, 5-13 parts of whole plant of Munronia unifoliolata Oliv., 6-14 parts of linaria buriatica tarcz.et benth., 6-14 parts of artemisia stelleriana, 6-14 parts of rhizome humata tyermanni, 6-14 parts of henbit deadnettle and 4-8 parts of liquorice root. By combining various medicines, the traditional Chinese medicine disclosed by the invention is capable of clearing heat and eliminating toxic factors, removing stasis and dredging collaterals, and regulating qi and blood, and the traditional Chinese medicine is not only effective in soothing liver but also capable of nourishing liver, so as to combine elimination and reinforcement to take effects of benefiting qi, removing toxins and dredging collaterals; the traditional Chinese medicine is significant in effects of relieving symptoms and signs, protecting liver and lowering enzyme, and reducing portal vein pressure; and the traditional Chinese medicine is concrete in curative effect and is free from obvious toxic and side effects.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating liver cirrhosis and portal hypertension of liver depression and spleen deficiency combined with blood stasis type. Background technique [0002] Liver cirrhosis is a chronic, diffuse, and progressive disease caused by a variety of pathogenic factors, mostly manifested as liver function damage and portal hypertension. The main manifestations of portal hypertension are splenomegaly, ascites, and esophageal and gastric varices. Among them, esophageal and gastric varices rupture and bleeding have the highest mortality rate, and esophageal varices are an objective manifestation of cirrhosis and portal hypertension. Therefore, endoscopic detection of esophageal varices is a reliable method for diagnosing cirrhosis and portal hypertension. By observing the esophageal varices before and after treatment The degree of c...

AI Technical Summary

Problems solved by technology

In recent years, the clinical and basic research of cirrhotic portal hypertension has made great progress, and the clinical prevention and treatment effects have also been greatly improved. However, the root cause of portal hypertension is cirrhosis, and modern medicine has not yet found an effective treatment for cirrhosis. Therefore, the current treatment for portal hypertension is mainly to prevent esophageal variceal bleeding and rebleeding after variceal bleeding, so as to reduce the mortality rate.

[0003] Western treatment mostly adopts symptomatic treatment, however, the curative effect is often not good, the reason is that Western medicine only aims at blocking one or more than two pathological links in the pathological process.